You just read:

Regeneron and Sanofi Receive Positive CHMP Opinion for Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis

News provided by

Regeneron Pharmaceuticals, Inc.

Apr 24, 2017, 01:00 ET